Instytut Matki i Dziecka
About Instytut Matki i Dziecka
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Anna Raciborska
3
Institute of Mother and Child, Warsaw, Poland
2
PTC Therapeutics
2
Amgen
1
Amzell
1
Gilead Sciences
1
Isofol Medical AB
1
Janssen Research & Development, LLC
1
University Hospital, Basel, Switzerland
1
Vertex Pharmaceuticals Incorporated
1
Clinical Trials at Instytut Matki i Dziecka
During the past decade, Instytut Matki i Dziecka conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on
average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
2011-12-01
2013-04-01
Completed
61
Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
2013-12-01
2017-01-03
Completed
18
Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
2014-08-01
2016-11-01
Completed
279
Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis
2015-08-31
2017-06-02
Terminated
246
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
2017-11-13
2023-07-25
Active, not recruiting
85
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
2019-11-20
2028-12-04
Recruiting
336
Three-dimensional Cleft Lip and Palate Morphology Prior to One-stage Cleft Repair
2020-12-07
2022-11-30
Recruiting
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instytut Matki i Dziecka" #1 sponsor was "Anna Raciborska" with 3 trials, followed by "Institute of Mother and Child, Warsaw, Poland" with 2 trials
sponsored, "PTC Therapeutics" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Amzell"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Matki i Dziecka"
#1 collaborator was "Maria Sklodowska-Curie National Research Institute of Oncology" with 4 trials as a collaborator, "Wrocław University of Environmental and Life Sciences" with 3 trials as a collaborator, "Łukasiewicz Research Network" with 3 trials as a collaborator, "Bielanski Hospital" with 1 trials as a collaborator and "Cystic Fibrosis Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Instytut Matki i Dziecka
According to Clinical.Site data, the most researched conditions in "Instytut Matki i Dziecka" are
"Cystic Fibrosis" (4 trials), "Histiocytosis" (3 trials), "Osteosarcoma" (2 trials), "Advanced Solid Tumor" (1 trials) and "Cleft Lip and Palate" (1 trials). Many other conditions were trialed in "Instytut Matki i Dziecka" in a lesser frequency.
Clinical Trials Intervention Types at Instytut Matki i Dziecka
Most popular intervention types in "Instytut Matki i Dziecka" are "Drug" (12 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "AMZ002 injectable solution, 0.5mg/mL" (1 trials), "AZLI" (1 trials), "Ataluren" (1 trials) and "Ataluren (PTC124®)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instytut Matki i Dziecka
The vast majority of trials in "Instytut Matki i Dziecka" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Instytut Matki i Dziecka
Currently, there are NaN active trials in "Instytut Matki i Dziecka".
undefined are not yet recruiting,
7 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Instytut Matki i Dziecka,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instytut Matki i Dziecka, 2 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".